1-16 of 16
Hideo Tanaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapy Strategy for Lymphoma Based on Cancer Energy Metabolism of OPB-111077, a Novel Antitumor Agent Inhibiting Mitochondrial Oxidative Phosphorylation

Naoto Ohi, Mitsuhiro Okuno, Hideo Tanaka, Tadaaki Ohtani
Journal: Blood
Blood (2021) 138 (Supplement 1): 4363.
https://doi.org/10.1182/blood-2021-148979
Published: 2021
Journal Articles

Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial

Takashi Kumagai, Kazunori Murai, Hiroshi Ureshino, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Masayuki Mita, Nobuhiko Uoshima, Toru Kiguchi, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda, Kensuke Nakao, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yosuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
Journal: Blood
Blood (2021) 138 (Supplement 1): 3601.
https://doi.org/10.1182/blood-2021-149483
Published: 2021
Journal Articles

Discontinuation Of Dasatinib In Patients With CML Who Have Maintained Complete Molecular Response For At Least One Year: Results From a Prospective Discontinuation (DADI) Trial

Hideo Tanaka, MD, PhD, Jun Imagawa, MD, PhD, Masaya Okada, MD, PhD, Hirohisa Nakamae, MD, PhD, Masayuki Hino, MD, PhD, Kazunori Murai, MD, PhD, Yoji Ishida, M.D., Ph.D., Takashi Kumagai, MD, PhD, Seiichi Sato, MD, Kazuteru Ohashi, MD, PhD, Hisashi Sakamaki, MD, PhD, Hisashi Wakita, MD, PhD, Nobuhiko Uoshima, MD, PhD, Yasunori Nakagawa, MD, Yosuke Minami, MD, PhD, Masahiro Ogasawara, MD, PhD, Tomoharu Takeoka, MD, Hiroshi Akasaka, MD, Satoshi Morita, PhD, Junichi Sakamoto, MD, PhD, Shinya Kimura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3998.
https://doi.org/10.1182/blood.V122.21.3998.3998
Published: 2013
Journal Articles

Rapid and Sustained Increase of LGL and Rare CMV-Reactivation During Dasatinib Treatments in CML

Hideo Tanaka, MD, Shizuka Nakashima, Miyuki Usuda
Journal: Blood
Blood (2011) 118 (21): 2752.
https://doi.org/10.1182/blood.V118.21.2752.2752
Published: 2011
Journal Articles

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia

Brief Report
Jun Imagawa, Yuka Harada, Takeshi Shimomura, Hideo Tanaka, Yoshiko Okikawa, Hideo Hyodo, Akiro Kimura, Hironori Harada
Journal: Blood
Blood (2010) 116 (26): 6018–6022.
https://doi.org/10.1182/blood-2010-06-289389
Published: 2010
Journal Articles

Seven-Year Follow-up of Patients Receiving Imatinib for the Treatment of Chronic Myelogenous Leukemia by the TARGET System

Tetsuzo Tauchi, M.D., Masahiro Kizaki, M.D., Shinichiro Okamoto, M.D., Hideo Tanaka, M.D., Mitsune Tanimoto, M.D., Koiti Inokuchi, M.D., Tohru Murayama, M.D., Yoshio Saburi, M.D., Masayuki Hino, M.D., Mitsuru Tsudo, M.D., Taizo Shimomura, M.D., Yasushi Isobe, M.D., Kazuo Oshimi, MD, Kazuo Dan, M.D., Kazuma Ohyashiki, M.D., Yasuo Ikeda, M.D.
Journal: Blood
Blood (2010) 116 (21): 2287.
https://doi.org/10.1182/blood.V116.21.2287.2287
Published: 2010
Journal Articles

Alcohol Drinking, Smoking, Past History of Gastroduodenal Ulcer, Height, and Risk of API2-MALT1 Fusion Positive and Negative Gastric MALT Lymphoma Among Japanese.

Takakazu Kawase, Keitaro Matsuo, Tsuneya Nakamura, Junya Kanda, Hidemi Ito, Satoyo Hosono, Miki Watanabe, Yasushi Yatabe, Yasuo Morishima, Kazuo Tajima, Masao Seto, Shigeo Nakamura, Hideo Tanaka
Journal: Blood
Blood (2009) 114 (22): 5010.
https://doi.org/10.1182/blood.V114.22.5010.5010
Published: 2009
Journal Articles

Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.

Yoshiaki Kuroda, MD, Akira Sakai, M.D., Naohiro Tsuyama, Ph.D., Yuta Katayama, M.D., Shoso Munemasa, M.D., Yoshiko Okikawa, M.D., Hideki Asaoku, M.D., Nanae Nakaju, Mami Mizuno, Takashi Nishizaka, M.D., Katsunari Ogawa, Hideo Tanaka, M.D., Akiro Kimura, M.D.
Journal: Blood
Blood (2007) 110 (11): 3530.
https://doi.org/10.1182/blood.V110.11.3530.3530
Published: 2007
Journal Articles

MEL1 at 1p36.3 Is Fused to Several Partner Genes Including HOXA9 Located at Different Chromosomal Bands from 3q21.3 in t(1;3)(p36.3;q21.3)-Leukemia.

Phan Thi Xinh, MD, PhD, Hoang Anh, VU, M.D, Ph.D, Hideo Tanaka, M.D, Ph.D, Shin Fujisawa, M.D, Ph.D, Fumitoshi Taketazu, M.D, Ph.D, Janet D. Rowley, M.D, Katsushi Tokunaga, Ph.D, Yuko Sato, M.D, Ph.D
Journal: Blood
Blood (2007) 110 (11): 3499.
https://doi.org/10.1182/blood.V110.11.3499.3499
Published: 2007
Journal Articles

The Bcr-Abl Kinase Inhibitor INNO-406 Induces Autophagy and Different Modes of Cell Death Execution in Bcr-Abl-Positive Leukemias.

Yuri Kamitsuji, MD, Junya Kuroda, PhD, Shinya Kimura, PhD, Ken-ichiro Watanabe, PhD, Eishi Ashihara, PhD, Yoshihiro Yui, MD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Hideo Tanaka, PhD, Eri Kawata, MD, Taira Maekawa, MD, Tatsutoshi Nakahata, PhD, Souichi Adachi, PhD
Journal: Blood
Blood (2007) 110 (11): 2951.
https://doi.org/10.1182/blood.V110.11.2951.2951
Published: 2007
Journal Articles

Interferon-γ Attenuates the Survival Activity of G-CSF through PI3K/Akt Signaling Pathway in Mouse Multipotent Progenitor Cells.

Hong Liu, MD, PhD, Keichiro Mihara, MD,Ph.D, Hideo Tanaka, MD,Ph.D, Akiro Kimura, MD,Ph.D
Journal: Blood
Blood (2006) 108 (11): 4163.
https://doi.org/10.1182/blood.V108.11.4163.4163
Published: 2006
Journal Articles

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Yuri Kamitsuji, MD, Souichi Adachi, MD, PhD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Ken-Ichiro Watanabe, MD, PhD, Hideo Tanaka, MD, PhD, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, Tatsutoshi Nakahata, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2177.
https://doi.org/10.1182/blood.V108.11.2177.2177
Published: 2006
Journal Articles

IFNα Therapy Up-Regulates Serum Soluble TRAIL Levels and Induces Marked TRAIL mRNA Expressions in Polymorphonuclear Neutrophils in Chronic Myeloid Leukemia Patients.

Hideo Tanaka, MD, Takuo Ito, MD, Akiro Kimura, MD
Journal: Blood
Blood (2005) 106 (11): 2885.
https://doi.org/10.1182/blood.V106.11.2885.2885
Published: 2005
Journal Articles

Identification of the Genomic Breakpoints at 1p36.3 and 3q21.3 in Five MDS/AML(M4) Patients with t(1;3)(p36;q21) Translocation. GATA2 Mutation May Be Involved in Leukemogenesis.

Phan Thi Xinh, M.D., Hoang Anh Vu, M.D., Fumitoshi Taketazu, M.D., Ph.D., Shin Fujisawa, M.D., Ph.D., Hideo Tanaka, M.D., Ph.D., Fumiharu Yagasaki, M.D., Ph.D., Atsushi Toyoda, Ph.D., Yoshiyuki Sakaki, Ph.D., Janet D. Rowley, M.D., Katsushi Tokunaga, Ph.D., Yuko Sato, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2899.
https://doi.org/10.1182/blood.V104.11.2899.2899
Published: 2004
Journal Articles

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia

Hironori Harada, Yuka Harada, Hideo Tanaka, Akiro Kimura, Toshiya Inaba
Journal: Blood
Blood (2003) 101 (2): 673–680.
https://doi.org/10.1182/blood-2002-04-1010
Published: 2003
Journal Articles

A novel gene, MEL1 , mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells

Naomi Mochizuki, Seiichi Shimizu, Toshiro Nagasawa, Hideo Tanaka, Masafumi Taniwaki, Jun Yokota, Kazuhiro Morishita
Journal: Blood
Blood (2000) 96 (9): 3209–3214.
https://doi.org/10.1182/blood.V96.9.3209
Published: 2000